Overview

Effects of GLP-1 Receptor Agonist on Fat Redistribution and Inflammatory Status

Status:
Unknown status
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
GLP-1 receptor agonists promote fat redistribution in obese women with type 2 diabetes, reduce liver fat content, improve the inflammation state
Phase:
N/A
Details
Lead Sponsor:
Shanghai 10th People's Hospital
Treatments:
Exenatide